Reference
Shakir KMM, et al. Successful treatment of a patient with statin-induced myopathy and myotonic dystrophy type 2 with PCSK9 inhibitor, alirocumab (PraluentTM). Endocrine Reviews 38 (Suppl.): No. 3, Jun 2017. Available from: URL: https://endo.confex.com/endo/2017endo/meetingapp.cgi/Paper/30408 [abstract] - USA
Rights and permissions
About this article
Cite this article
Antihyperlipidaemics. Reactions Weekly 1661, 35 (2017). https://doi.org/10.1007/s40278-017-33323-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-33323-8